An FDA advisory panel is reviewing Aimmune’s peanut allergy therapy. Here’s what’s happening

We’re monitoring today’s meeting of the FDA advisory committee on Palforzia, a novel but controversial treatment that uses calibrated quantities of ingested peanut powder to protect people against severe peanut allergy. Check back here often for updates throughout the day.